In suspected bronchogenic carcinoma, which imaging test is used for staging rather than initial screening?

In suspected bronchogenic carcinoma, which imaging test is used for staging rather than initial screening?

• A. CT Scan
• B. Chest X-Ray
• C. Sputum Cytology
• D. Pleural Fluid Analysis

Answer: (A)

Staging determines how far the cancer has spread and guides treatment decisions, so the imaging chosen should show the tumor’s extent and involvement of surrounding structures. A CT scan of the chest with contrast provides detailed cross-sectional images that reveal the tumor’s size and exact location, as well as involvement of mediastinal and hilar lymph nodes, invasion into the chest wall or mediastinal vessels, and any intrathoracic metastases. This level of detail is what clinicians rely on to assign a stage and plan therapy. Chest X-ray can raise suspicion by showing a mass, but it doesn’t reliably define extent or nodal involvement, so it’s not sufficient for staging. Sputum cytology and pleural fluid analysis are cytologic tests used to confirm cancer cells or evaluate effusions; they don’t describe the anatomic spread needed for staging. In contrast, CT is the imaging workhorse for staging, providing the anatomical map needed to determine how advanced the disease is.

Staging determines how far the cancer has spread and guides treatment decisions, so the imaging chosen should show the tumor’s extent and involvement of surrounding structures. A CT scan of the chest with contrast provides detailed cross-sectional images that reveal the tumor’s size and exact location, as well as involvement of mediastinal and hilar lymph nodes, invasion into the chest wall or mediastinal vessels, and any intrathoracic metastases. This level of detail is what clinicians rely on to assign a stage and plan therapy.

Chest X-ray can raise suspicion by showing a mass, but it doesn’t reliably define extent or nodal involvement, so it’s not sufficient for staging. Sputum cytology and pleural fluid analysis are cytologic tests used to confirm cancer cells or evaluate effusions; they don’t describe the anatomic spread needed for staging. In contrast, CT is the imaging workhorse for staging, providing the anatomical map needed to determine how advanced the disease is.